Investor Invenomic Capital Management LP
13D/G Filings

This page shows a list of all the recent 13D/G filings made by Invenomic Capital Management LP . Schedule 13D is commonly referred to as a “beneficial ownership report.” The term "beneficial owner" is defined under SEC rules. It includes any person who directly or indirectly shares voting power or investment power (the power to sell the security).

When a person or group of persons acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities, they are required to file a Schedule 13D within ten days after the purchase. Click the link icon to see the full transaction history.

Add This Fund
to your dashboard

Date Form Target Prev
Shares		 Current
Shares		 Change
(Percent)		 Ownership
(Percent)		 Change
(Percent)
2024-11-14 13G/A LEXX / Lexaria Bioscience Corp. 731,981 567,650
2024-02-14 13G/A LEXX / Lexaria Bioscience Corp. 473,103 731,981
2024-02-14 13G/A DSP / Viant Technology Inc. 803,390 439,371
2024-02-14 13G/A UFI / Unifi, Inc. 944,290 813,753
2023-02-10 13G UFI / Unifi, Inc. 944,290
2023-02-10 13G DSP / Viant Technology Inc. 803,390
2023-02-10 13G/A LEXX / Lexaria Bioscience Corp. 359,113 473,103
2022-03-10 13G/A IMMR / Immersion Corporation 1,698,555 1,669,161
2022-02-14 13G LEXX / Lexaria Bioscience Corp. 359,113 359,113
2022-02-14 13G IMMR / Immersion Corporation 1,698,555 1,698,555